Novo Nordisk plans to reduce the price of its diabetes drug, Ozempic, in response to cheaper generic versions launched by ...

India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based g ...

The conference will serve as a strategic platform to accelerate the sector’s transition from a volume-driven industry to a value- and innovation-led global powerhouse.

Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.

Union Minister of State for Science and Technology, Jitendra Singh, stated that India is steadily evolving into a robust ...

Takeda is launching a restructuring, targeting nearly $1.3 billion in annual savings. Generic versions of Novo Nordisk's ...

Advice comes at a time when India accounts for a 5th of global generic drug supply & 40% of generics used in US. However, ...

India’s pharmaceutical sector must accelerate research-to-market timelines, strengthen clinical trial infrastructure and reduce dependence on imported bulk drugs to remain globa ...

Following the patent expiry of semaglutide in India, leading pharma companies including Sun Pharma, Dr Reddy’s, Zydus, and ...

NEW DELHI (Reuters) -Indian pharmaceutical firms failed to follow rules that every batch of medicinal ingredients is tested, the country's drug regulator said on Wednesday, following the deaths of 17 ...

In this article, we will take a look at the top 15 pharmaceutical companies in India. For more companies, click Top 5 Pharmaceutical Companies in India. India is the largest producer of generic ...